| Financial Year |
March 31 2023 |
| Monetary Funds |
803,707,289.76 |
| Held-for-trading Financial Assets |
16,005,983.98 |
| Notes Receivable |
-- |
| Accounts Receivable |
129,997,864.34 |
| Advances to Suppliers |
300,353,385.76 |
| Other Receivables |
146,341,306.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,323,002,905.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
138,387,894.16 |
| Other Current Assets |
247,576,718.02 |
| Total Current Assets |
4,215,228,137.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
246,882,916.98 |
| Investment Properties |
19,387,298.53 |
| Fixed Assetes |
1,033,829,994.08 |
| Under-construction Projects |
22,437,616.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
326,750,883.98 |
| R&D expenses |
-- |
| Goodwill |
191,394,422.51 |
| Long-Term Deferred and Prepaid Expenses |
17,288,861.92 |
| Deferred Income Tax Assets |
14,895,076.46 |
| Other Non-Current Assets |
33,544,782.34 |
| Sub-Total of Non-Current Assets |
1,933,011,885.80 |
| Total Assets |
6,148,240,023.29 |
| Short-Term Loans |
1,259,632,767.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
114,946,488.82 |
| Accounts Received In Advance |
1,322,687.64 |
| Employee Compensation Payable |
23,593,266.20 |
| Taxes Payable |
37,166,153.17 |
| Interest Payable |
21,082,795.47 |
| Dividend Payable |
3,213,302.88 |
| Other payables |
96,624,629.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,110,914.89 |
| Other Current Liabilities |
19,616,104.25 |
| Sub-Total of Current Liabilities |
1,903,766,245.09 |
| Long-term Loans |
600,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
66,404,235.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
736,843,108.11 |
| Total Liabilities |
2,640,609,353.20 |
| Paid-In Capital(Or Share Stock) |
726,950,251.00 |
| Capital Surplus |
1,678,678,350.95 |
| Surplus Reserve |
122,122,436.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
570,169,756.04 |
| Minority Stockholder's Interest |
408,932,516.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,098,698,153.62 |
| Owner's Equity（Stockholder's Equity） |
3,507,630,670.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,148,240,023.29 |
